Published on 14 September 2023
The incorporation of the Halal Management System (HMS) by the pharmaceutical industry
halal assurance, halal pharmaceuticals, oral dosage, supply chain
DOI: 10.5639/gabij.2023.1203.014
7.414 views
Published on 14 September 2023
halal assurance, halal pharmaceuticals, oral dosage, supply chain
DOI: 10.5639/gabij.2023.1203.014
7.414 views
Published on 08 August 2023
biosimilar development, ethnic sensitivity assessments, global access, monoclonal antibodies, multi-regional clinical trials, regulatory reforms
DOI: 10.5639/gabij.2023.1202.010
10.515 views
Published on 04 May 2023
DOI: 10.5639/gabij.2023.1202.009
4.874 views
Published on 04 May 2023
biologicals, biosimilars, Canada, ophthalmology
DOI: 10.5639/gabij.2023.1202.008
5.660 views
Published on 03 May 2023
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2023.1201.001
1.392 views
Published on 02 March 2023
Author(s): Sílvia Helena Cestari de Oliveira, MSc
biologicals, biosimilars, Brazil
DOI: 10.5639/gabij.2023.1202.011
6.624 views
Published on 02 March 2023
biologicals, biosimilars, forced-switching, interchangeable biosimilar, non-medical switching
DOI: 10.5639/gabij.2023.1201.006
6.133 views
Published on 05 January 2023
Author(s): Robin Thorpe, PhD, FRCPath
biosimilars, clinical trials, guidance, immunogenicity, regulatory
DOI: 10.5639/gabij.2023.1201.002
5.026 views
Published on 05 January 2023
biosimilars, immunogenicity, interchangeability, switch studies
DOI: 10.5639/gabij.2023.1201.005
7.609 views
Published on 05 January 2023
bioequivalence, new branded generics, sitagliptin hydrochloride, sitagliptin phosphate
DOI: 10.5639/gabij.2023.1201.004
7.559 views
Published on 03 January 2023
1.120 views
Published on 29 December 2022
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2022.1103.014
1.503 views